Related Experiment Video
Updated: May 9, 2026
08:34
Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
[Probiotics in liver diseases]
Germán Soriano1, Elisabet Sánchez, Carlos Guarner
1Servicio de Patología Digestiva, Institud de Recerca IIB-Sant Pau, Hospital de Santa Creu i Sant Pau, Barcelona, España. GSoriano@santpau.cat
Nutricion Hospitalaria
|July 16, 2013
Summary
Probiotics show promise in managing liver diseases like cirrhosis by improving gut health and reducing inflammation. Further research is needed to confirm their effectiveness and safety for liver patients.
Area of Science:
- Gastroenterology and Hepatology
- Microbiology
- Immunology
Context:
- Liver diseases, including cirrhosis and non-alcoholic steatohepatitis (NASH), are significantly influenced by gut microbiota dysbiosis and inflammation.
- Intestinal alterations are critical factors in the progression and complication development of various liver conditions.
Purpose:
- To explore the potential of probiotics in managing liver diseases.
- To review the mechanisms by which probiotics may benefit patients with liver conditions.
- To assess the current evidence for probiotic efficacy in liver disease complications.
Summary:
- Probiotics demonstrate potential in modulating intestinal flora, reducing intestinal permeability, and suppressing inflammatory responses, thereby potentially delaying disease progression in liver patients.
- Studies suggest probiotics are effective in treating minimal hepatic encephalopathy and preventing overt hepatic encephalopathy episodes.
- Probiotics may also prevent postoperative bacterial infections and ameliorate liver damage in non-alcoholic steatohepatitis.
Impact:
- Probiotics offer a potential therapeutic strategy to improve outcomes and prevent complications in patients with liver diseases.
- Further investigation is required to establish definitive efficacy, optimal strains, and safety profiles for probiotic use in liver disease management.
- Understanding the precise mechanisms of probiotic action is crucial for optimizing their clinical application in hepatology.
Related Concept Videos
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:22Probiotics
Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:30Liver Physiology
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
01:17Gastritis-II: Pathophysiology
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...